Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 284 followers
Latest posts
Last updated about 10 hours ago
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 14, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 28, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation...
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Date of authorisation: 01/10/2008, Revision: 19, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil...
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 37, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of...
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 17, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 13, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation...
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 31, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 40, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of...
Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 10, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation...
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Revision: 1, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 18, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation...